I think the BAR answered that in part, "Typically, EOS operates in an industry where it can take an extended period of time (including up to, and beyond, twelve months) for new market opportunities to be converted into signed sales contracts". Adding to that, defence procurement can sometimes bring about variations to the contract even after it's signed eg. the customer may add to or reduce the original deliverable specifications, there may be confidentiality clauses associated with the procurement, and in the US (and elsewhere), different levels of security to pass before "invited" to tender.
Defence companies generally try to manage shareholder expectations by providing sufficient information that things are clicking over on. Global events can change rapidly and having 'good officers' (trust & respect) with customers and sensitivity to their needs is premium.
Just a few thoughts on it.
- Forums
- ASX - By Stock
- Ann: Business Activity Statement & Appendix 4C - Dec-22 Qtr
EOS
electro optic systems holdings limited
Add to My Watchlist
2.26%
!
$2.71

I think the BAR answered that in part, "Typically, EOS operates...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$2.71 |
Change
0.060(2.26%) |
Mkt cap ! $522.9M |
Open | High | Low | Value | Volume |
$2.68 | $2.78 | $2.67 | $3.647M | 1.341M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 40141 | $2.70 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.73 | 10000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 40141 | 2.700 |
1 | 10000 | 2.680 |
1 | 5000 | 2.670 |
1 | 70 | 2.660 |
6 | 20598 | 2.650 |
Price($) | Vol. | No. |
---|---|---|
2.740 | 1649 | 2 |
2.750 | 3722 | 3 |
2.770 | 2000 | 1 |
2.780 | 23384 | 7 |
2.790 | 4579 | 2 |
Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
Featured News
EOS (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online